Kala Bio KALA
NASDAQ KALA
$0.16 +0.01 (+6.67%)
At close: Nov 6, 2026 · 4:00 PM EST

Kala Bio (KALA) FCF Margin (2019 - 2022)

Updated

Kala Bio's FCF Margin was -2035.48% in FY2022, down 1064.66 percentage points from -970.83% in FY2021.

Analysis

Kala Bio (KALA) FCF Margin (2019 - 2022) Analysis & Trends

From FY2015 onward, Kala Bio has reported FCF Margin for 5 years.

  • FCF Margin shows a three-year change of -487.00 percentage points (FY2019 to FY2022).
  • The FY2022 figure marks the lowest annual FCF Margin since FY2015.
  • Per Business Quant data, FCF Margin in earlier years was -970.83% in FY2021 (+485.26 pp), -1456.08% in FY2020 (+92.40 pp) and -1548.49% in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Eli Lilly 1,224.11 Bn 1,197.72 Bn 20.46 Bn 33.69%
2 Johnson & Johnson 665.34 Bn 585.20 Bn 17.30 Bn 25.03%
3 AbbVie 515.72 Bn 483.73 Bn 13.12 Bn 41.97%
4 Merck 362.64 Bn 325.58 Bn 13.19 Bn 30.51%
5 Novartis Ag 315.51 Bn 288.75 Bn - -
6 Astrazeneca 289.26 Bn 263.15 Bn 13.26 Bn 52.85%
7 Amgen 249.20 Bn 200.85 Bn 7.58 Bn 35.25%
8 Gilead Sciences 207.48 Bn 182.59 Bn 6.73 Bn 57.81%
9 Pfizer 167.49 Bn 114.85 Bn 12.56 Bn 28.96%
10 Kala Bio 2.38 Mn -42.27 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 -3,738.81%
Jun 30, 2022 -1,218.62%
Mar 31, 2022 -1,761.66%
Dec 31, 2021 -1,504.09%
Sep 30, 2021 -861.17%
Jun 30, 2021 -718.91%
Mar 31, 2021 -1,006.09%
Dec 31, 2020 -1,179.71%
Sep 30, 2020 -1,179.50%
Jun 30, 2020 -2,386.19%
Mar 31, 2020 -1,883.47%
Dec 31, 2019 -1,559.32%
Sep 30, 2019 -1,593.11%
Jun 30, 2019 -1,017.26%
Mar 31, 2019 -2,280.95%
API Access

Kala Bio FCF Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=fcf-margin&ticker=KALA&period=max&api_key=YOUR_API_KEY